20-35115584-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018217.3(EDEM2):c.1586C>A(p.Ala529Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,613,706 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00011 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0000082 ( 0 hom. )
Consequence
EDEM2
NM_018217.3 missense
NM_018217.3 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: 3.64
Genes affected
EDEM2 (HGNC:15877): (ER degradation enhancing alpha-mannosidase like protein 2) In the endoplasmic reticulum (ER), misfolded proteins are retrotranslocated to the cytosol and degraded by the proteasome in a process known as ER-associated degradation (ERAD). EDEM2 belongs to a family of proteins involved in ERAD of glycoproteins (Mast et al., 2005 [PubMed 15537790]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03666067).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EDEM2 | NM_018217.3 | c.1586C>A | p.Ala529Glu | missense_variant | 11/11 | ENST00000374492.8 | NP_060687.2 | |
EDEM2 | NM_001145025.2 | c.1475C>A | p.Ala492Glu | missense_variant | 10/10 | NP_001138497.1 | ||
MMP24-AS1-EDEM2 | NM_001355008.2 | c.1463C>A | p.Ala488Glu | missense_variant | 15/15 | NP_001341937.1 | ||
EDEM2 | NR_026728.2 | n.1880C>A | non_coding_transcript_exon_variant | 10/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EDEM2 | ENST00000374492.8 | c.1586C>A | p.Ala529Glu | missense_variant | 11/11 | 1 | NM_018217.3 | ENSP00000363616.3 | ||
EDEM2 | ENST00000374491.3 | c.1475C>A | p.Ala492Glu | missense_variant | 10/10 | 1 | ENSP00000363615.2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 151812Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
17
AN:
151812
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251470Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135912
GnomAD3 exomes
AF:
AC:
8
AN:
251470
Hom.:
AF XY:
AC XY:
5
AN XY:
135912
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727248
GnomAD4 exome
AF:
AC:
12
AN:
1461894
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000112 AC: 17AN: 151812Hom.: 1 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74172
GnomAD4 genome
AF:
AC:
17
AN:
151812
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
74172
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2024 | The c.1586C>A (p.A529E) alteration is located in exon 11 (coding exon 11) of the EDEM2 gene. This alteration results from a C to A substitution at nucleotide position 1586, causing the alanine (A) at amino acid position 529 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MutPred
Gain of solvent accessibility (P = 0.0456);.;
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at